piper sandler cava - Search News

CAVA Group is recommended at Piper Sandler

CAVA Group is recommended at Piper Sandler after recent stumble

Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at Neutral. Analyst Brian Mullan and his team see CAVA (NYSE:CAVA) as one of the best ways to invest in the secular growth of fast casual,

Hosted on MSN · 3d

Piper Sandler Upgrades CAVA Group (CAVA)

Fintel reports that on February 28, 2025, Piper Sandler upgraded their outlook for CAVA Group (NYSE:CAVA) from Neutral to Overweight. Analyst Price Forecast Suggests 68.24% Upside As of February 19, 2025,

YAHOO!Finance · 4d

Piper Sandler bumps Cava to overweight after stock pullback

Piper Sandler upgraded CAVA Group Inc (NYSE:CAVA) to “Overweight” from “Neutral” following a sharp pullback in its stock given strong fundamentals and long-term growth potential in the fast-casual restaurant sector.

Business Insider · 4d

Cava Group upgraded to Overweight from Neutral at Piper Sandler

Piper Sandler analyst Brian Mullan upgraded Cava Group (CAVA) to Overweight from Neutral with a price target of $115, down from $142. The firm

Fintel on MSN · 3d

Piper Sandler Downgrades Teleflex (TFX)

Fintel reports that on February 28, 2025, Piper Sandler downgraded their outlook for Teleflex (NYSE:TFX) from Overweight to Neutral. Analyst Price Forecast Suggests 84.68% Upside As of February 18, 2025,

Walgreens downgraded, Cava Group upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Piper Sandler Sticks to Its Buy Rating for Illumina (ILMN)

Piper Sandler analyst David Westenberg maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $190.00.

Star Tribune27d

Ramstad: Inside Piper Sandler’s bond desk, a small-town firefighter shapes the world

Piper Sandler bond chief Jeremy Goebel at his desk on the trading floor Tuesday, Feb. 4. (Aaron Lavinsky/The Minnesota Star Tribune) ...

Avalo Therapeutics (NASDAQ:AVTX) Now Covered by Piper Sandler

Piper Sandler began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set an “overweight” rating and a $48.00 ...

Stocktwits on MSN1d

Cava's Retail Investors Remain Extremely Bullish After Analyst's Upgrade Citing Brighter Future For Fast-Casual Dining

Shares of CAVA Group Inc. (CAVA) ended Friday over 5% higher after the Mediterranean fast-casual restaurant chain received an ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results